FastFacts: Adenovirus Vector Manufacturing Platform Using CIMmultus QA Assures the Supply of Safe Vaccines

Watch the video or read the poster to learn:

• Why downstream processing remains one of the main bottlenecks in adenoviral vector manufacturing
• How an adenoviral vector purification platform using CIMmultus™ QA as the key purification step, secures a fast and robust process with better purity
• CIMmultus QA offers high capacity and high yields of adenovirus, results in cost reduction and overcomes raw material supply bottlenecks

Speaker:
Hana Jug, Project Manager in process development for viral vectors and vaccines, Sartorius BIA Separations